Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: A multicenter study
Authors:
- Jeffrey L. AndersonJAJeffrey L. Anderson
- Donald S. BaimDBDonald S. Baim
- Steven A. FeinSFSteven A. Fein
- Richard A. GoldsteinRGRichard A. Goldstein
- Thierry H. LeJemtelTLThierry H. LeJemtel
- Mariell J. LikoffMLMariell J. Likoff
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- New Positive Inotropic Agents in the Treatment of Congestive Heart FailureNew England Journal of Medicine, 1986
- Vasodilator Therapy of Heart FailureNew England Journal of Medicine, 1984
- Drugs Five Years LaterAnnals of Internal Medicine, 1983
- Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1983
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- The natural history of idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1981
- Tolerance to dobutamine after a 72 hour continuous infusionThe American Journal of Medicine, 1980
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- The Natural History of Congestive Heart Failure: The Framingham StudyNew England Journal of Medicine, 1971